Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial
Chinese RCT (n=889 with impaired glucose tolerance) found Jinlida granules 9g daily reduced the incidence of diabetes vs placebo (hazard ratio, 0.59; 95% CI, 0.46-0.74; P <0.001) after a median follow-up of 2.2 years. Fasting blood glucose level and HbA1c also lower with Jinlida.
Source:
JAMA Internal Medicine
SPS commentary:
Jinlida is a traditional Chinese medicine preparation containing 17 different herbal components. A related editorial discusses the study findings and notes the difficulties in the path to FDA approval for herbal products.